{"url":"https://www.livemint.com/market/stock-market-news/multibagger-ipo-bse-sme-stock-sudarshan-pharma-industries-turns-1-17-lakh-of-allottees-into-6-4-lakh-in-1-5-years-11728981997588.html","title":"Multibagger IPO: BSE SME stock turns  ₹1.17 lakh of allottees into  ₹6.4 lakh in 1.5 years; check details","description":"Multibagger IPO: The stock has rewarded patient investors as it surged 448 per cent with respect to its issue price until the closing of October 14, 2024. It hit its 52-week high of  ₹452.70 on October 3 after hitting a 52-week low of  ₹58.20 on June 4 this year.","content":"SME IPO: As the Indian capital market buzzes with a surge of small and medium-sized enterprises (SME) initial public offerings (IPOs), marked by strong investor interest yet lacklustre performances, it’s the perfect moment to hit rewind and revisit some of the past IPOs that truly delivered impressive returns for investors, proving their worth amid the current market frenzy.Take, for instance, a book-built IPO worth  ₹50.10 crore that made its debut in the Indian primary market on March 9, 2023, closing on March 14 with a modest subscription of just 1.06 times. Despite its lukewarm reception, this stock took everyone by surprise post-listing on March 22, 2023, skyrocketing by an astounding 448 per cent over the past 1.5 years, proving that even the quietest entries can make the loudest impacts.The stock we are talking about is Sudarshan Pharma Industries.Sudarshan Pharma Industries IPO opened for public subscription on March 9 last year with a price band of  ₹71 to  ₹73 per share. The issue saw a tepid response from investors as it was subscribed just 1.06 times. The minimum amount of investment required by retail investors was  ₹1,16,800. The stock made a flat entry at  ₹73 on the BSE SME on March 22 last year.The stock has rewarded patient investors as it surged 448 per cent with respect to its issue price until the closing of October 14, 2024. It hit its 52-week high of  ₹452.70 on October 3 after hitting a 52-week low of  ₹58.20 on June 4 this year. On a monthly scale, it saw a massive gain of 124 per cent last month. However, it is witnessing some profit-making this month and has declined 5 per cent in October so far.Since its market debut, this stock's impressive performance could have transformed a  ₹1.17 lakh investment into a striking  ₹6.4 lakh in just a little over a year and a half.In an exchange filing on October 14, the company announced the acquisition of 2,09,100 shares of  ₹10 each of Ishwari Healthcare Private Limited, equivalent to 51 per cent of the paid-up equity share capital of the company. Upon the completion of the acquisition, Ishwari Healthcare would become a subsidiary of the company.Additionally, in a separate exchange filing on September 30, the company's board approved the proposal for a sub-division or split of its equity shares, presently having a face value of  ₹10 each, into 10 equity shares of the company having a face value of  ₹1.Read all market-related news here","cleaned_content":"sme ipo as the indian capital market buzzes with a surge of small and medium sized enterprises sme initial public offerings ipos marked by strong investor interest yet lacklustre performances it s the perfect moment to hit rewind and revisit some of the past ipos that truly delivered impressive returns for investors proving their worth amid the current market frenzy take for instance a book built ipo worth \u003cFIVE_TEN\u003e crore that made its debut in the indian primary market on march \u003cNINE_\u003e \u003cTWO_THOUSAND\u003e closing on march \u003cONE_TEN\u003e with a modest subscription of just \u003cONE_\u003e times despite its lukewarm reception this stock took everyone by surprise post listing on march \u003cTWO_TEN\u003e \u003cTWO_THOUSAND\u003e skyrocketing by an astounding \u003cFOUR_HUNDRED_PERCENT\u003e over the past \u003cONE_\u003e years proving that even the quietest entries can make the loudest impacts the stock we are talking about is sudarshan pharma industries sudarshan pharma industries ipo opened for public subscription on march \u003cNINE_\u003e last year with a price band of \u003cSEVEN_TEN\u003e to \u003cSEVEN_TEN\u003e per share the issue saw a tepid response from investors as it was subscribed just \u003cONE_\u003e times the minimum amount of investment required by retail investors was \u003cONE_HUNDRED_THOUSAND\u003e the stock made a flat entry at \u003cSEVEN_TEN\u003e on the bse sme on march \u003cTWO_TEN\u003e last year the stock has rewarded patient investors as it surged \u003cFOUR_HUNDRED_PERCENT\u003e with respect to its issue price until the closing of october \u003cONE_TEN\u003e \u003cTWO_THOUSAND\u003e it hit its \u003cFIVE_TEN\u003e week high of \u003cFOUR_HUNDRED\u003e on october \u003cTHREE_\u003e after hitting a \u003cFIVE_TEN\u003e week low of \u003cFIVE_TEN\u003e on june \u003cFOUR_\u003e this year on a monthly scale it saw a massive gain of \u003cONE_HUNDRED_PERCENT\u003e last month however it is witnessing some profit making this month and has declined \u003cFIVE_PERCENT\u003e in october so far since its market debut this stocks impressive performance could have transformed a \u003cONE_\u003e lakh investment into a striking \u003cSIX_\u003e lakh in just a little over a year and a half in an exchange filing on october \u003cONE_TEN\u003e the company announced the acquisition of \u003cTWO_HUNDRED_THOUSAND\u003e shares of \u003cONE_TEN\u003e each of ishwari healthcare private limited equivalent to \u003cFIVE_TEN_PERCENT\u003e of the paid up equity share capital of the company upon the completion of the acquisition ishwari healthcare would become a subsidiary of the company additionally in a separate exchange filing on september \u003cTHREE_TEN\u003e the companys board approved the proposal for a sub division or split of its equity shares presently having a face value of \u003cONE_TEN\u003e each into \u003cONE_TEN\u003e equity shares of the company having a face value of \u003cONE_\u003e read all market related news here","timestamp":"2024-10-15T15:20:00+05:30","market_timestamp":"2024-10-15T15:20:00+05:30","off_market_hours":false}